1. Home
  2. SER vs MATH Comparison

SER vs MATH Comparison

Compare SER & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • MATH
  • Stock Information
  • Founded
  • SER 2017
  • MATH 2015
  • Country
  • SER United States
  • MATH Hong Kong
  • Employees
  • SER N/A
  • MATH N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • MATH Finance/Investors Services
  • Sector
  • SER Health Care
  • MATH Finance
  • Exchange
  • SER Nasdaq
  • MATH Nasdaq
  • Market Cap
  • SER 56.5M
  • MATH 60.8M
  • IPO Year
  • SER 2018
  • MATH N/A
  • Fundamental
  • Price
  • SER $5.80
  • MATH $3.21
  • Analyst Decision
  • SER Strong Buy
  • MATH
  • Analyst Count
  • SER 1
  • MATH 0
  • Target Price
  • SER $11.00
  • MATH N/A
  • AVG Volume (30 Days)
  • SER 16.6K
  • MATH 289.7K
  • Earning Date
  • SER 08-08-2025
  • MATH 08-26-2025
  • Dividend Yield
  • SER N/A
  • MATH N/A
  • EPS Growth
  • SER N/A
  • MATH N/A
  • EPS
  • SER N/A
  • MATH 0.17
  • Revenue
  • SER $51,000.00
  • MATH $31,399,049.00
  • Revenue This Year
  • SER N/A
  • MATH N/A
  • Revenue Next Year
  • SER N/A
  • MATH N/A
  • P/E Ratio
  • SER N/A
  • MATH $19.18
  • Revenue Growth
  • SER N/A
  • MATH 291.58
  • 52 Week Low
  • SER $3.81
  • MATH $0.80
  • 52 Week High
  • SER $11.57
  • MATH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • SER 57.53
  • MATH 51.60
  • Support Level
  • SER $5.50
  • MATH $2.88
  • Resistance Level
  • SER $6.29
  • MATH $3.52
  • Average True Range (ATR)
  • SER 0.52
  • MATH 0.34
  • MACD
  • SER 0.03
  • MATH -0.09
  • Stochastic Oscillator
  • SER 74.44
  • MATH 33.79

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

Share on Social Networks: